Easywell Biomedicals Current Ratio vs. Book Value Per Share
| 1799 Stock | TWD 67.90 3.10 4.78% |
For Easywell Biomedicals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Easywell Biomedicals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Easywell Biomedicals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Easywell Biomedicals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Easywell Biomedicals over time as well as its relative position and ranking within its peers.
Easywell |
Easywell Biomedicals Book Value Per Share vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Easywell Biomedicals's current stock value. Our valuation model uses many indicators to compare Easywell Biomedicals value to that of its competitors to determine the firm's financial worth. Easywell Biomedicals is number one stock in current ratio category among its peers. It is rated fifth in book value per share category among its peers creating about 1.06 of Book Value Per Share per Current Ratio. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Easywell Biomedicals' earnings, one of the primary drivers of an investment's value.Easywell Book Value Per Share vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Easywell Biomedicals |
| = | 6.64 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Easywell Biomedicals |
| = | 7.01 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Easywell Book Value Per Share Comparison
Easywell Biomedicals is currently under evaluation in book value per share category among its peers.
Easywell Biomedicals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Easywell Biomedicals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Easywell Biomedicals will eventually generate negative long term returns. The profitability progress is the general direction of Easywell Biomedicals' change in net profit over the period of time. It can combine multiple indicators of Easywell Biomedicals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Easywell Biomedicals, Inc., a biopharmaceutical and medical device company, develops and commercializes medical devices, drug substances, and pharmaceutical dosage forms in Taiwan and internationally. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan. EASYWELL BIOMEDICAL operates under Medical Devices classification in Taiwan and is traded on Taiwan OTC Exchange.
Easywell Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Easywell Biomedicals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Easywell Biomedicals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Easywell Biomedicals' important profitability drivers and their relationship over time.
Use Easywell Biomedicals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Easywell Biomedicals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Easywell Biomedicals will appreciate offsetting losses from the drop in the long position's value.Easywell Biomedicals Pair Trading
Easywell Biomedicals Pair Trading Analysis
The ability to find closely correlated positions to Easywell Biomedicals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Easywell Biomedicals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Easywell Biomedicals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Easywell Biomedicals to buy it.
The correlation of Easywell Biomedicals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Easywell Biomedicals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Easywell Biomedicals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Easywell Biomedicals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Easywell Biomedicals position
In addition to having Easywell Biomedicals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Software Thematic Idea Now
Software
Companies that develop and distribute software and software systems to individuals or business. The Software theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Software Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Easywell Stock Analysis
When running Easywell Biomedicals' price analysis, check to measure Easywell Biomedicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easywell Biomedicals is operating at the current time. Most of Easywell Biomedicals' value examination focuses on studying past and present price action to predict the probability of Easywell Biomedicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easywell Biomedicals' price. Additionally, you may evaluate how the addition of Easywell Biomedicals to your portfolios can decrease your overall portfolio volatility.